KORU Medical Systems, Inc. (KRMD)
(Delayed Data from NSDQ)
$4.16 USD
+0.12 (2.97%)
Updated Sep 19, 2025 04:00 PM ET
After-Market: $4.17 +0.01 (0.24%) 7:58 PM ET
2-Buy of 5 2
D Value A Growth D Momentum C VGM
Fundamental Charts
About Cash from Investing (TTM)
The company's trailing twelve month (TTM) Cash from Investing is the sum of the company's past 12 months cash position resulting from any gains or losses from investments in the financial markets, operating activities, and changes resulting from amounts spent on investments in capital assets such as plant and equipment. When evaluating the Cash from Investing value, it is important to consider each of the various activities which contribute to the overall change in cash position. A company can have a negative cash flow from investing and have a positive cash from Cash from operations or financing.
KRMD 4.16 +0.12(2.97%)
Will KRMD be a Portfolio Killer in September?
Zacks Investment Research is releasing its prediction for KRMD based on the 1-3 month trading system that more than doubles the S&P 500.
Zacks News for KRMD
Are You Looking for a Top Momentum Pick? Why KORU Medical Systems, Inc. (KRMD) is a Great Choice
KORU Medical Systems, Inc. (KRMD) Reports Break-Even Earnings for Q2
KRMD: What are Zacks experts saying now?
Zacks Private Portfolio Services
American Well Corporation (AMWL) Reports Q2 Loss, Beats Revenue Estimates
Omnicell (OMCL) Beats Q2 Earnings and Revenue Estimates
KORU Medical Systems Inc. (KRMD) Reports Q1 Loss, Tops Revenue Estimates
Other News for KRMD
Is KRMD poised for gains? Crossed Above 20 Day Moving Average shows up after advancing 2.97%
Craig-Hallum Reaffirms Their Buy Rating on REPRO-MED Systems (KRMD)
Is KRMD consolidating before a move? Bollinger Band Squeeze shows up after rising 2.02%
REPRO-MED Systems (KRMD) Receives a Buy from Canaccord Genuity
Lake Street Reaffirms Their Buy Rating on REPRO-MED Systems (KRMD)